BusinessOtonomy Successfully Completes Phase 2 Clinical Trial of OTIPRIO® in Pediatric Patients with Acute Otitis Media with Tympanostomy TubesBy Nasdaq OMXOct 4, 2016, 11:30 AM UTC
BusinessOtonomy to Present at Cowen and Company Health Care ConferenceBy Nasdaq OMXFeb 29, 2016, 12:30 PM UTC
BusinessOtonomy to Report Fourth Quarter and Full Year 2015 Financial Results and Provide Corporate UpdateBy Nasdaq OMXFeb 26, 2016, 12:30 PM UTC
BusinessOtonomy Announces Publication Supporting Development of OTO-104 as Protectant Against Cisplatin-Induced Hearing LossBy Nasdaq OMXJan 26, 2016, 12:05 PM UTC
BusinessOtonomy Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional SharesBy Nasdaq OMXJan 12, 2016, 2:27 PM UTC
